In this white paper, members of the iBio team demonstrate that FastPharming System, along with Glycaneering™ and iBio's in-house advanced bioanalytics, provides a compelling platform to spur innovation and accelerate the development and manufacture of therapeutic and bioprocess mAbs.
.svg)
